Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of MCS® in Prostate Cancer Prevention

NCT02042807 is registered in ClinicalTrials.gov with Health Ever Bio-Tech Co., Ltd. as lead sponsor.

NCT NCT02042807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of MCS® in Prostate Cancer Prevention
Lead sponsor
Health Ever Bio-Tech Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2014
Completion date
December 31, 2024
Enrollment
702 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer